Neuspera Medical Inc.

Neuspera Medical Inc. company information, Employees & Contact Information

Neuspera Medical, Inc. is committed to developing implantable medical device technology that will improve the lives of patients battling chronic illness. With the first intended indication for use as Urinary Urgency Incontinence (UUI), the platform technology is ultimately designed to deliver targeted bioelectronic medicine for a variety of conditions. Neuspera’s minimally-invasive implants with external wearable transmitters offer the possibility for therapies to reach deeper, harder to access anatomical locations in the body.

Company Details

Employees
43
Address
San Jose, Ca
Phone
1(888)846-8332
Email
In****@****era.com
Industry
Medical Device
HQ
San Jose, CA
Looking for a particular Neuspera Medical Inc. employee's phone or email?

Neuspera Medical Inc. Questions

News

Neuspera Medical Receives FDA Approval for First Integrated Sacral Neuromodulation (iSNM) System for Urinary Urge Incontinence - PR Newswire

Neuspera Medical Receives FDA Approval for First Integrated Sacral Neuromodulation (iSNM) System for Urinary Urge Incontinence PR Newswire

FDA approves integrated sacral neuromodulation system for urinary urge incontinence - Urology Times

FDA approves integrated sacral neuromodulation system for urinary urge incontinence Urology Times

Neuspera Medical Announces Landmark Six-Month Clinical Trial Results for the First Battery-Free Percutaneous Sacral Neuromodulation (pSNM) System for Urgency Urinary Incontinence Management - PR Newswire

Neuspera Medical Announces Landmark Six-Month Clinical Trial Results for the First Battery-Free Percutaneous Sacral Neuromodulation (pSNM) System for Urgency Urinary Incontinence Management PR Newswire

Pivotal study data show efficacy of percutaneous SNM device for UUI - Urology Times

Pivotal study data show efficacy of percutaneous SNM device for UUI Urology Times

Neuspera Medical Raises $23 Million in Series D Financing - PR Newswire

Neuspera Medical Raises $23 Million in Series D Financing PR Newswire

NEUSPERA MEDICAL® ANNOUNCES FDA CLEARANCE OF ITS SYSTEM FOR PERIPHERAL NERVE STIMULATION - PR Newswire

NEUSPERA MEDICAL® ANNOUNCES FDA CLEARANCE OF ITS SYSTEM FOR PERIPHERAL NERVE STIMULATION PR Newswire

NEUSPERA MEDICAL® ANNOUNCES FIRST SUCCESSFUL IMPLANT OF THE NUVELLA™ SYSTEM IN THE SECOND PHASE OF ITS SANS-UUI IDE CLINICAL TRIAL - PR Newswire

NEUSPERA MEDICAL® ANNOUNCES FIRST SUCCESSFUL IMPLANT OF THE NUVELLA™ SYSTEM IN THE SECOND PHASE OF ITS SANS-UUI IDE CLINICAL TRIAL PR Newswire

Neuspera Medical Announces Close of a $65M Series C Equity Financing - PR Newswire

Neuspera Medical Announces Close of a $65M Series C Equity Financing PR Newswire

Neuspera Medical Completes First Implants of its Neuromodulation Device in its two-stage Pivotal Clinical Trial to treat Urinary Urgency Incontinence - PR Newswire

Neuspera Medical Completes First Implants of its Neuromodulation Device in its two-stage Pivotal Clinical Trial to treat Urinary Urgency Incontinence PR Newswire

Top Neuspera Medical Inc. Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant